The two "types" of the disease are not precise enough - and the adult-onset varieties of the disease should be split into five distinct categories, according to the paper in The Lancet Diabetes and Endocrinology.
Researchers identified genetically marked groupings of the disease that vary by severity, age at which they most often occur and probable complications.
"We stratified patients into five subgroups with differing disease progression and risk of diabetic complications", the authors write. I only have to look at my mum's workload to see that: as a diabetes specialist nurse, she's busier than ever, supporting patients throughout day to day management of their condition and some of the more serious complications of the disease, from blindness to kidney failure and limb amputation.
Furthermore, maybe their treatment should all the more intently reflect patients who are right now classed as type 1.
Insulin-deficient patients who had auto-antibodies associated with autoimmune diabetes (cluster 1: severe autoimmune diabetes, affecting around 6-15%), a form of diabetes formerly called type 1 diabetes, or latent autoimmune diabetes in adults (LADA) comprised the other severe group.
After analyzing the data of almost 15,000 diabetics using information taken from four registries in Sweden and Finland, the team found that Type 2 is actually made up of four categories, including two of the most severe types of the disease.
Be that as it may, analysts in Sweden and Finland think the more confounded picture they have revealed will introduce a time of customized drug for diabetes. Subgroup classification was validated in three independent cohorts. "They clearly need insulin very soon, nearly as much as "type 1", he said.
The researchers identified five clusters in both men (n = 5,334) and women (n = 3,646) in the ANDIS cohort.
The second cluster was patients who showed insulin deficiency and were GADA negative. Other clinical characteristics were similar to cluster 1, although this group had the highest proportion of patients on metformin. A recent analysis found that the number of people with diabetes in the United Kingdom had doubled in the past 20 years.
Bunch 2 patients would as of now be named type 2 as they don't have an immune system sickness. People with this type do not respond to insulin and have a high likelihood of developing liver and diabetic kidney disease.
Other researchers caution that the team's results need to be replicated elsewhere, using even more diverse patient samples. He said that this would lead to more precise diagnosis and treatment of diabetes tailored to individual needs.
Diabetes is now divided into type 1 diabetes (approximately 10%), type 2 diabetes (85-90%) and several less common diseases like latent autoimmune diabetes in adults (LADA), maturity onset diabetes of the young (MODY) and secondary diabetes.
The study, by Lund University Diabetes Center in Sweden and the Institute for Molecular Medicine Finland, took a gander at 14,775 patients including a point by point investigation of their blood. He mentioned a caveat saying that this study cohort was a uniform Scandinavian population and thus all races and ethnicities were not adequately represented.